Literature DB >> 659598

Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone.

A J Zeleznik, J Roth.   

Abstract

Based on studies of the interaction of insulin with its receptors in vitro, we calculated that a receptor compartment should be measurable directly in vivo. For this purpose, rabbits were injected intravenously with a labeled insulin that has low affinity for receptors in combination with a radioiodinated insulin that has high affinity for receptors. Plasma concentrations of labeled insulins were measured at selected intervals after injection. Apparent volumes of distribution were calculated by extrapolation of plasma distribution were calculated by extrapolation of plasma disappearance curves; high affinity insulins consistently distributed into spaces that were two-three times greater than those of the low affinity insulins. Injections of unlabeled pork insulin before tracer insulins decreased the distribution space of the high affinity insulin in a dose-dependent manner while having little or no effect on the distribution space of the low affinity labeled insulin. When unlabeled insulin was injected after the tracer insulins, there was an immediate rise in the plasma concentration of the high affinity insulin with only a slight change in the plasma concentration of the low affinity insulin. These results demonstrate that high affinity insulins distribute into a body compartment which has many properties of the insulin receptor previously studied in vitro. This receptor compartment: (a) recognizes insulins based on their biological potencies; (b) is saturated by elevated concentrations of insulin; and (c) insulin bound to receptors is in equilibrium with free hormone in plasma. Further, the bound to free ratios for hormone, calculated from these data, suggest that in vivo greater than 50% of the extrapancreatic insulin is bound to receptors during normal physiological states.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659598      PMCID: PMC372659          DOI: 10.1172/JCI109054

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  The destruction of I131-labeled insulin by rat liver extracts.

Authors:  I A MIRSKY; G PERISUTTI; F J DIXON
Journal:  J Biol Chem       Date:  1955-05       Impact factor: 5.157

2.  Transcortin: a corticosteroid-binding protein of plasma. V. In vitro inhibition of cortisol metabolism.

Authors:  A A SANDBERG; W R SLAUNWHITE
Journal:  J Clin Invest       Date:  1963-01       Impact factor: 14.808

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  Studies on the mechanism of capture and degradation of insulin-1131 by the cyclically perfused rat liver.

Authors:  G E MORTIMORE; F TIETZE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

5.  Proteins associated with the thyroid hormones.

Authors:  J ROBBINS; J E RALL
Journal:  Physiol Rev       Date:  1960-07       Impact factor: 37.312

6.  Iodoinsulin used to determine specific activity of iodine-131.

Authors:  S A Berson; R S Yalow
Journal:  Science       Date:  1966-04-08       Impact factor: 47.728

7.  In vivo and in vitro metabolism of insulin-I 131 and glucagon-I 131 in normal and cortisone-treated rabbits.

Authors:  S A BERSON; R S YALOW; B W VOLK
Journal:  J Lab Clin Med       Date:  1957-03

8.  Effects of superimposed native insulin on disposal of iodoinsulin in the body.

Authors:  A N WICK; D R DRURY
Journal:  Proc Soc Exp Biol Med       Date:  1958-03

9.  Effect of nephrectomy and splanchnicectomy on plasma disappearance of labeled insulin in the rabbit.

Authors:  D L PALMER; R E BOLINGER
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  14 in total

1.  Insulin entry into muscle involves a saturable process in the vascular endothelium.

Authors:  S Majumdar; A J Genders; A C Inyard; V Frison; E J Barrett
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

2.  Direct Activation of Angiotensin II Type 2 Receptors Enhances Muscle Microvascular Perfusion, Oxygenation, and Insulin Delivery in Male Rats.

Authors:  Fei Yan; Zhaoshun Yuan; Nasui Wang; Robert M Carey; Kevin W Aylor; Li Chen; Xinmin Zhou; Zhenqi Liu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  How the immunoassay transformed C-peptide from a duckling into a swan.

Authors:  J Roth; I Whitford; R Dankner; A L Szulc
Journal:  Diabetologia       Date:  2012-01-13       Impact factor: 10.122

4.  Pathways for insulin access to the brain: the role of the microvascular endothelial cell.

Authors:  Rick I Meijer; Sarah M Gray; Kevin W Aylor; Eugene J Barrett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-02       Impact factor: 4.733

5.  In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; S Treves; C R Kahn; R von Frenckell
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

6.  Insulin secretion and metabolism during the perinatal period in the rat. Evidence for a placental role in fetal hyperinsulinemia.

Authors:  F R Sodoyez-Goffaux; J C Sodoyez; C J De Vos
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

7.  Insulin is ubiquitous in extrapancreatic tissues of rats and humans.

Authors:  J L Rosenzweig; J Havrankova; M A Lesniak; M Brownstein; J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Further evidence that insulin metabolism is a major determinant of peripheral insulin response to oral glucose in subjects with mild glucose intolerance.

Authors:  E Bonora; I Zavaroni; V Manicardi; C Coscelli; U Butturini
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

9.  Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.

Authors:  J C Sodoyez; F Sodoyez Goffaux; R von Frenckell; C J De Vos; S Treves; C R Kahn
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Beta receptor occupancy. Assessment in the intact animal.

Authors:  C J Homcy; H W Strauss; S Kopiwoda
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.